These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1330367)

  • 1. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance.
    Triggle DJ
    Cleve Clin J Med; 1992; 59(6):617-27. PubMed ID: 1330367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive therapy and vascular wall protection with special reference to calcium antagonists].
    Faulhaber HD
    Z Arztl Fortbild (Jena); 1993; 87(9 Suppl 5):1-5. PubMed ID: 8237075
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium antagonists: sites of action, pharmacologic effect profile and clinical use. 2: Pharmacologic effects, indications and side effects of calcium antagonists].
    Bluth R; Langnickel R
    Z Arztl Fortbild (Jena); 1986; 80(6):237-40. PubMed ID: 2424182
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium, calcium channels, and calcium channel antagonists.
    Triggle DJ
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1474-81. PubMed ID: 1962736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive mechanism of action and binding sites of nitrendipine.
    Triggle DJ
    Am J Cardiol; 1986 Sep; 58(8):35D-38D. PubMed ID: 2429539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do calcium antagonists differ in clinical practice?
    Ferrari R; Cucchini F; Bolognesi R; Bachetti T; Boraso A; Bernocchi P; Gaia G; Visioli O
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():565-75. PubMed ID: 7841090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use].
    Högestätt ED; Andersson KE
    Lakartidningen; 1997 Sep; 94(36):3024-6, 3029-31. PubMed ID: 9312623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class IV antiarrhythmic agents: new compounds using an old strategy.
    Szentandrássy N; Nagy D; Hegyi B; Magyar J; Bányász T; P Nánási P
    Curr Pharm Des; 2015; 21(8):977-1010. PubMed ID: 25354181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists. Pharmacology and clinical pharmacology].
    Grobecker H
    Med Monatsschr Pharm; 1994 May; 17(5):130-9. PubMed ID: 8022361
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,4-Dihydropyridines as calcium channel ligands and privileged structures.
    Triggle DJ
    Cell Mol Neurobiol; 2003 Jun; 23(3):293-303. PubMed ID: 12825828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From channels to cats: an overview of isradipine pharmacology.
    Rüegg UT; Hof RP
    Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use.
    Opie LH
    Prog Cardiovasc Dis; 1996; 38(4):273-90. PubMed ID: 8552787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist.
    Triggle DJ
    Am J Cardiol; 1996 Nov; 78(9A):7-12. PubMed ID: 8903279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel antagonists. What do the second-generation agents have to offer?
    Salerno SM; Zugibe FT
    Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the calcium channel blockers.
    Stone KS; Scordo KA
    Heart Lung; 1984 Sep; 13(5):563-73. PubMed ID: 6088433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonism in vascular smooth muscle cells.
    Fleckenstein-Grün G
    Pflugers Arch; 1996; 432(3 Suppl):R53-60. PubMed ID: 8994543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and vasodilatation.
    Godfraind T
    Pharmacol Ther; 1994 Oct; 64(1):37-75. PubMed ID: 7846116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacology of calcium antagonists.
    Wilson TW; Quest DW
    Can J Cardiol; 1995 Mar; 11(3):243-9. PubMed ID: 7889444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.